Syncrosome is a preclinical CRO dedicated to In vivo pharmacology since 12 years now and with a strong competency in Efficacy and Pharmacokinetics.
FENS Forum of Neuroscience 2012 Barcelona
One of our departments is dedicated to Central Nervous System with relevant techniques : The Microdialysis and CSF sampling. Moreover, we performed also models in Parkison's diease (haloperidol, 6-OHDA and L-DOPA) and Stroke (MCAO).
Sandra Robelet, Head of Central Nervous System departement, will pre...
Are you attending "Preclinical Safety and Efficacy Testing for New Drugs" Annual meeting in Zurich?
I would like to invite you to meet Syncrosome representatives:
Sandra Robelet, CNS Study Director,
Emmanuelle Bettendorf, Account Manager,
at "Preclinical Safety and Efficacy Testing for New Drugs", Nov. 29 - Dec. 1 in Zurich.
Syncrosome is a Preclinical Drug Evaluation Company specialised in human health - we perform pharmacological in vivo studies on physiopathological models.
Syncrosome is a Preclinical Drug Evaluation Company specialised in human and animal health in vivo pharmacological studies. Syncrosome has the professional expertise to complete studies independently or to work in parallel with in-house research teams, after preliminary in vitro screenings - www.syncrosome.com